Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
(2023, August 28)
The trials weren't designed to directly compare the pill and injection, so the numbers aren't head-to-head
One of the most commonly reported side effects across GLP-1 types is nausea, a sick-to-the-stomach feeling that often creates an urge to vomit, and a loss of appetite
Results showed that GLP-1 receptor agonists and SGLT2 inhibitors were superior in reducing the risk of MACE when compared to DPP-4 inhibitors (HR 086 [082089] and 086 [082090], respectively), but no difference was found between SGLT2 inhibitors and GLP-1 receptor agonists in reducing rate of MACE (HR of 101 (094107)) (68)
Browse other research areas
US$ 21.76
US$ 25.18
US$ 29.56
US$ 26.76
